Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
10/13/2009 | CA2384037C Pyrazolo[4,3-d]pyrimidines |
10/08/2009 | WO2009123241A1 Inhibitor of plasminogen activator inhibitor-1 |
10/08/2009 | WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof |
10/08/2009 | US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content |
10/08/2009 | US20090253767 Aminoindazolylurea derivatives |
10/08/2009 | US20090253766 Thiophene derivatives as factor xia inhibitors |
10/08/2009 | US20090253711 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
10/08/2009 | US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use |
10/08/2009 | US20090253676 Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes |
10/08/2009 | US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists |
10/08/2009 | US20090252678 Cox-2-targeted imaging agents |
10/08/2009 | CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof |
10/08/2009 | CA2685716A1 Compounds for treating muscular dystrophy |
10/07/2009 | EP2106213A2 Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
10/07/2009 | EP1663985B1 Pesticides |
10/07/2009 | EP1506260B1 Trisazo dyes for ink jet printing |
10/07/2009 | CN101553473A Substituted pyrazoles, compositions containing these, method of production and use |
10/07/2009 | CN100546979C 4-[4-(diethylaminoethyl )phenyl]methylene-5-ethoxy-2,4-dihydro-2-phenyl-3H-pyrazolyl -3-one preparation method |
10/06/2009 | US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
10/06/2009 | US7598395 Heterocyclocarboxamide derivatives |
10/06/2009 | US7598389 Silylated carboxamides |
10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
10/06/2009 | US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
10/06/2009 | US7598285 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance |
10/06/2009 | US7598284 Indazole compounds as B3 adrenoceptor agonist |
10/06/2009 | US7597879 selected from manganese cis-urocanate gluconate, manganese cis-urocanate, and manganese cis-urocanate glycinate; reduction of topical peroxide including hydrogen peroxide, reduction of topical inflammation including sunburn, increased sun protection of skin, the reduction of skin wrinkles |
10/06/2009 | CA2427617C Medicinal compositions for concomitant use as anticancer agent |
10/01/2009 | WO2009119880A1 Substituted pyrazole derivatives and use thereof |
10/01/2009 | WO2009119088A1 Heterocyclic compound |
10/01/2009 | WO2009118175A1 Novel p2x7r antagonists and their use |
10/01/2009 | WO2009118168A1 Substituted 4-aminocyclohexane derivatives |
10/01/2009 | US20090247586 Carboxamides for controlling micro-organisms in plant and material protection |
10/01/2009 | US20090247547 Hydroxamate-based inhibitors of deacetylases b |
10/01/2009 | US20090247525 Sigma receptor inhibitors |
10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
10/01/2009 | US20090247506 Antibacterial agents |
10/01/2009 | US20090247504 Indazole Derivatives for Treatment of Alzheimer's Disease |
10/01/2009 | CA2719745A1 Novel p2x7r antagonists and their use |
10/01/2009 | CA2719735A1 Substituted 4-aminocyclohexane derivatives |
10/01/2009 | CA2718727A1 Heterocyclic compound |
09/30/2009 | EP2105164A1 Novel P2X7R antagonists and their use |
09/30/2009 | EP2104664A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein |
09/30/2009 | EP2104663A2 Method for producing substituted pyrazolecarboxylic acid chlorides |
09/30/2009 | CN101547909A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
09/30/2009 | CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof |
09/30/2009 | CN101544607A Method for synthesizing 1-aryl pyrazole compound containing trifluoromethylsulfinyl |
09/30/2009 | CN101544606A Malononitrile compound and use thereof |
09/29/2009 | US7595399 Tyrosine derivatives |
09/29/2009 | US7595344 Sulphones which modulate the action of gamma secretase |
09/29/2009 | US7595343 Inhibitors of histone deacetylase |
09/29/2009 | US7595339 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics |
09/29/2009 | US7595337 Mitotic kinesin inhibitors |
09/29/2009 | US7595332 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
09/29/2009 | US7595320 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, process for preparing them, compositions containing them and use thereof |
09/29/2009 | US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
09/29/2009 | US7595162 Methods of labeling polynucleotides with energy transfer dyes |
09/29/2009 | CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors |
09/29/2009 | CA2315647C Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas |
09/24/2009 | WO2009117626A2 Methods for making central nervous system agents that are trpv1 antagonists |
09/24/2009 | WO2009116558A1 1-phenyl-5-difluoromethylpyrazole-4-carboxamide derivative and herbicide containing the same as active ingredient |
09/24/2009 | WO2009116435A1 Method for producing fluorine-containing acylacetic acid derivative, method for producing fluorine-containing pyrazolecarboxylic acid ester derivative, and method for producing fluorine-containing pyrazolecarboxylic acid derivative |
09/24/2009 | WO2009116290A1 4-halogenobenzoyl derivatives having sulfoxyimino group and herbicides |
09/24/2009 | WO2009116151A1 1-phenyl-5-difluoromethylpyrazole-4-carboxamide derivatives and herbicides containing the derivatives as the active ingredient |
09/24/2009 | WO2009115515A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
09/24/2009 | WO2009115252A2 Substituted pyrazolamides and the use thereof |
09/24/2009 | WO2009035949A3 Soluble epoxide hydrolase inhibitors |
09/24/2009 | US20090240061 Method for forming a carbon-carbon or carbon-heteroatom bond |
09/24/2009 | US20090240058 Activator for Peroxisome Proliferator-Activating Receptor Delta |
09/24/2009 | US20090239911 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
09/24/2009 | US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
09/24/2009 | US20090239841 Diaryl Ureas as CB1 Antagonists |
09/24/2009 | DE102008015032A1 Substituierte Pyrazolamide und ihre Verwendung Substituted Pyrazolamides and their use |
09/24/2009 | CA2719018A1 Methods for making central nervous system agents that are trpv1 antagonists |
09/24/2009 | CA2718693A1 Substituted pyrazolamides and the use thereof |
09/24/2009 | CA2717922A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
09/23/2009 | EP2103215A1 Herbicide containing benzoylpyrazole compound |
09/23/2009 | EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
09/23/2009 | EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
09/23/2009 | EP2102168A1 Acylaminopyrazoles for treating cardiovascular diseases |
09/23/2009 | EP2102166A2 Process for producing 5-aminopyrazole derivative, and azo dye |
09/23/2009 | EP2102165A2 N-(methyl)-1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
09/23/2009 | EP1709003B1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole |
09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
09/23/2009 | CN101541758A Indazole derivatives that inhibit TRPV1 and uses thereof |
09/23/2009 | CN101541757A Pyrazoline compounds as mineralocorticoid receptor antagonists |
09/23/2009 | CN101541756A Pyrazoles as glucokinase activators |
09/23/2009 | CN101541755A Benzoylpyrazole compounds, process for their production and herbicides containing them |
09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
09/23/2009 | CN101538243A Malononitrile compound and use thereof |
09/23/2009 | CN100542530C 3'- (2z)- 1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
09/22/2009 | US7592363 Indazoles |
09/22/2009 | US7592354 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
09/22/2009 | US7592338 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
09/17/2009 | WO2009112522A1 (E)-N-(2-Amino-phenyl)-3-{1-[4-(1-methyl-1H-pyrazol-4-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide salts |
09/17/2009 | WO2009112157A1 Process for the regioselective synthesis of l-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives |
09/17/2009 | US20090234135 pyrazolium cation with fluorosulfonate or fluorosulfonylimide anions; use as solvents, catalysts |
09/17/2009 | US20090234117 Pyrazolopyrimidine Derivative |
09/17/2009 | US20090233901 Vla-4 inhibitory drug |